TALL-1, a
member of the tumour necrosis factor (TNF) family, plays an important role in
the immune response by costimulating B lymphocyte proliferation. It is the subject
of intense research and patents are being sought relating to the use of TALL-1
(also known as BAFF or BlyS) to treat inflammatory and immune-related diseases
including lupus and cancer. The crystal structure of the functional, soluble component
of the molecule, sTALL-1, in complexes with two of its receptors, is now reported.
The structure reveals a mode of binding very different to that seen in other TNFreceptor
complexes.
Ligand-receptor
binding revealed by the TNF family member TALL-1 YINGFANG
LIU, XIA HONG, JOHN KAPPLER , LING JIANG, RONGGUANG ZHANG, LIANGGUO XU, CHEOL-HO
PAN, WESLEY E. MARTIN, ROBERT C. MURPHY, HONG-BING SHU, SHAODONG DAI & GONGYI
ZHANG Nature423, 4956 (2003); doi:10.1038/nature01543
| Summary |
Full Text (HTML
/ PDF) |